Jennifer Kornberg
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
Journal: Journal of hepatocellular carcinoma
Published: March 12, 2022
Prophylactic Anti-Cytomegalovirus Hyperimmunoglobulin in Critically Ill Liver Transplant Patients: Impact on Early Immunology and Survival.
Journal: Journal of clinical medicine
Published: January 31, 2020
The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma.
Journal: Journal of surgical oncology
Published: May 28, 2019
Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
Journal: Digestive diseases and sciences
Published: June 15, 2018
Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma.
Journal: Scientific reports
Published: June 13, 2017
Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: December 09, 2015
Treating ischaemia-reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation.
Journal: Alimentary pharmacology & therapeutics
Published: April 26, 2015
Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients.
Journal: Digestive diseases and sciences
Published: November 26, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026